Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
Summary
Third Opinion Trial Synopsis:
This is a test to see if a new medicine called selinexor is safe and works well for people with a type of cancer called multiple myeloma. The people in the test have tried other treatments but they didn't work.
This is a test to see if a new medicine called selinexor is safe and works well for people with a type of cancer called multiple myeloma. The people in the test have tried other treatments but they didn't work.
*Third Opinion AI Generated Synopsis
Trial Summary
This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to lenalidomide-containing regimens with or without steroids.
This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to lenalidomide-containing regimens with or without steroids.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: